# MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon

> **NCT07326735** · PHASE4 · COMPLETED · sponsor: **Frisch Medical Device Private Limited** · enrollment: 360 (actual)

## Conditions studied

- Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

## Interventions

- **DEVICE:** Mamba Sirolimus-Eluting PTCA Balloon
- **DEVICE:** Percutaneous Coronary Angioplasty with Sirolimus-Coated Balloon

## Key facts

- **NCT ID:** NCT07326735
- **Lead sponsor:** Frisch Medical Device Private Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-11
- **Primary completion:** 2024-01-22
- **Final completion:** 2024-03-03
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07326735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07326735, "MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07326735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*